Yukiko Sagawa

High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer

Yusuke Okuma, Yukio Hosomi, Yoshiro Nakahara et al. · Lung Cancer · 2016 · 178 citations

Medicine, Cancer Biology, Oncology +13

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer

Yusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi et al. · Clinical Lung Cancer · 2018 · 145 citations

Medicine, Oncology, Pharmacology +16

Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response

Akitaka Takahara, Shigeo Koido, Masaki Ito et al. · Cancer Immunology Immunotherapy · 2011 · 59 citations · Full text

Medicine, Oncology, Pharmacology +14

Antitumour activity mediated by CD4⁺ cytotoxic T lymphocytes against MHC class II‐negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin‐12

Sadamu Homma, Hideo Komita, Yukiko Sagawa et al. · Immunology · 2005 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses

Sadamu Homma, Yukiko Sagawa, Masaki Ito et al. · Clinical & Experimental Immunology · 2006 · 45 citations · Full text

Medicine, Immunology, Oncology +17